Clinical consultation, a personal perspective: Components of a successful integrative medicine clinical consultation

Journal of the Society for Integrative Oncology

Volumn 6, Issue 3, 2008, Pages 129-133

  Frenkel, Moshe ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Alternative medicine; Cancer care; Complementary medicine; Integrative medicine; Medical education; Patient doctor communication

Indexed keywords

ALTERNATIVE MEDICINE; ARTICLE; CANCER PATIENT; CLINICAL EFFECTIVENESS; COMMUNICATION SKILL; CONSULTATION; DOCTOR PATIENT RELATION; INTEGRATIVE MEDICINE; MEDICAL EDUCATION; PATIENT CARE; RELIABILITY; SENSITIVITY ANALYSIS;

ANTINEOPLASTIC AGENTS; COMMUNICATION; COMPLEMENTARY THERAPIES; DELIVERY OF HEALTH CARE, INTEGRATED; EDUCATION, MEDICAL; EMPATHY; HERBAL MEDICINE; HUMANS; INTEGRATIVE MEDICINE; NEOPLASMS; PATIENT ACCEPTANCE OF HEALTH CARE; PHYSICIAN-PATIENT RELATIONS; REFERRAL AND CONSULTATION;

EID: 51549086489     PISSN: 1715894X     EISSN: None     Source Type: Journal    
DOI: 10.2310/7200.2008.0017     Document Type: Article

References (26)

1. Consortium of Academic Health Centers for Integrative Medicine. Definition of integrative medicine. Available at: http://www.imconsortium.org/cahcim/about/home.html (accessed October 21, 2007).
2. Society for Integrative Oncology. SIO mission. Available at: http://www.integrativeonc.org/index.php?scn=aboutus (accessed October 21, 2007).
3. Richardson NLA, Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 2000;18:2505-14.
4. Ernst E, Cassileth BR. The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer 1998; 83:777-82.
5. Ben-Arye E, Bar-Sela G, Frenkel M, et al. Is a biopsychosocial-spiritual approach relevant to cancer treatment? A study of patients and oncology staff members on issues of complementary medicine and spirituality. Support Care Cancer 2006;14:147-52.
6. Paltiel O, Avitzour M, Peretz T, et al. Determinants of the use of complementary therapies by patients with cancer. J Clin Oncol 2001;19:2439-48.
7. Newell S, Sanson-Fisher RW. Australian oncologists' self-reported knowledge and attitudes about non-traditional therapies used by cancer patients. Med J Aust 2000;172:110-3.
8. Bourgeault IL. Physicians' attitudes toward patients' use of alternative cancer therapies. CMAJ 1996;155:1679-85.
9. Navo MA, Phan J, Vaughan C, et al. An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies. J Clin Oncol 2004;22:671-7.
10. Dy GK, Bekele L, Hanson LJ, et al. Complementary and alternative medicine use by patients enrolled onto phase I clinical trials. J Clin Oncol 2004;22:4810-5.
11. Epstein RM. Mindful practice. JAMA 1999;282:833-9.
12. Rees RW, Feigel I, Vickers A, et al. Prevalence of complementary therapy use by women with breast cancer. A population-based survey. Eur J Cancer 2000;36:1359-64.
13. Rabow MW, Dibble SL, Pantilat SZ, et al. The comprehensive care team: a controlled trial of outpatient palliative medicine consultation. Arch Intern Med 2004;164:83-91.
14. Crocetti E, Crotti N, Feltrin A, et al. The use of complementary therapies by breast cancer patients attending conventional treatment. Eur J Cancer 1998;34:324-8.
15. Miller M, Boyer MJ, Butow PN, et al. The use of unproven methods of treatment by cancer patients. Frequency, expectations and cost. Support Care Cancer 1998;6:337-47.
16. Wyatt GK, Friedman LL, Given CW, et al. Complementary therapy use among older cancer patients. Cancer Pract 1999;7:136-44.
17. Morant R, Jungi WF, Koehli C, et al. Why do cancer patients use alternative medicine? Schweiz Med Wochenschr 1991;121:1029-34.
18. Kappauf H, Leykauf-Ammon D, Bruntsch U, et al. Use of and attitudes held towards unconventional medicine by patients in a department of internal medicine/oncology and hematology. Support Care Cancer 2000;8:314-22.
19. Oneschuk D, Fennell L, Hanson J, et al. The use of complementary medications by cancer patients attending an outpatient pain and symptom clinic. J Palliat Care 1998;14:21-6.
20. Tasaki K, Maskarinec G, Shumay DM, et al. Communication between physicians and cancer patients about complementary and alternative medicine: exploring patients' perspectives. Psychooncology 2002;11:212-20.
21. Fernandez CV, Stutzer CA, MacWilliam L, et al. Alternative and complementary therapy use in pediatric oncology patients in British Columbia: prevalence and reasons for use and nonuse. J Clin Oncol 1998;16:1279-86.
22. Von Gruenigen VE, White LJ, Kirven MS, et al. A comparison of complementary and alternative medicine use by gynecology and gynecologic oncology patients. Int J Gynecol Cancer 2001;11:205-9.
23. Frenkel M, Ben-Arye E, Baldwin CD, et al. Approach to communicating with patients about the use of nutritional supplements in cancer care. South Med J 2005;98:289-94.
24. Lee CO. Herbs and cytotoxic drugs: recognizing and communicating potentially relevant interactions. Clin J Oncol Nurs 2005;9: 481-7.
25. Lee AH, Ingraham SE, Kopp M, et al. The incidence of potential interactions between dietary supplements and prescription medications in cancer patients at a Veterans Administration hospital. Am J Clin Oncol 2006;29:178-82.
26. Rinpoche S. The Tibetan book of living and dying. 2nd rev ed. San Francisco (CA): Rider & Co.; 2002.